Lewis will fix him tomorrow.
They basically washed out 2 good news from yesterday and today.
It is very strange in front of NTM data to downgrade and based on data that has been out there for some time.
I never trust Anal-ist.
Agreed here. There has been no news just based on analyst opinion basically saying that he was somewhat wrong before...Think there are other motives here as Wedbush was one of the few firms left out in the last fundraising round...:) Perhaps some sour grapes for not getting any banking fees? Also their pt doesn't make sense as they didn't come out and say that they thought data would be negative for NTM. There is limited options for patients suffering from NTM so with positive data from upcoming trial I believe FDA will work with the company to make this available to the public quickly...Today is a buying opportunity imo. GL to all